Download PDFPDF
Clinician guide to COVID-19 diagnostics
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    History must not be allowed to repeat itself
    • oscar,m jolobe, retired geriatrician BMA, also a member(but not an affiliate) of the Manchester Medical Society

    In order to avoid repetition of the mistakes that have been made in the ascertainment of asymptomatic status in adults who might have COVID-19 infection(1) healthcare practitioners in paediatrics must ascertain the full currently known range of COVID-19 symptoms before a child is declared to be asymptomatic. In the event of an oligosymptomatic or monosymptomatic clinical presentation each of those children with sparse or atypical symptoms should be fully followed up to ascertain if the "stand alone" symptoms are "joined" by new symptoms or whether the oligosymptomatic status persists throughout the course of that child's illness.
    Finally, in conformity with the principles of Bayes' Theorem, frontline healthcare workers should be issued with a nomogram spelling out the post test probability of COVID-19 infection(2) in the event of a negative RT-PCR test result. The nomogram should be the subject of regular re-evaluation and updating, on the basis of new information about the authenticity of new symptoms reportedly associated with COVID-19.
    I have no funding and no conflict of interest
    (1) Saurabh S., Vohra S
    What should be the criteria for determining asymptomatic status in COVID-19
    QJMed 2020; Article in Press
    (2) Chan GM
    Bayes theorem, Covid-19, and screening tests
    Amer J Emerg Med 2020;38:2011-2013

    Conflict of Interest:
    None declared.